[
  {
    "ts": null,
    "headline": "Truist Lowers GitLab (GTLB) PT to $75, Maintains Buy Rating",
    "summary": "GitLab Inc. (NASDAQ:GTLB) is one of the best technology stocks according to Wall Street analysts. Earlier on June 12, Truist adjusted the price target for GitLab to $75 from $80, while maintaining a Buy rating on the shares. This revision comes after GitLab’s Q1 2025 results, which, although exceeding guidance, did not meet investor expectations […]",
    "url": "https://finnhub.io/api/news?id=1c4b12a3a1d1923c282b60335a2d45f08ef3ee21a579aecc925a47775107ab3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750705885,
      "headline": "Truist Lowers GitLab (GTLB) PT to $75, Maintains Buy Rating",
      "id": 135487041,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "GitLab Inc. (NASDAQ:GTLB) is one of the best technology stocks according to Wall Street analysts. Earlier on June 12, Truist adjusted the price target for GitLab to $75 from $80, while maintaining a Buy rating on the shares. This revision comes after GitLab’s Q1 2025 results, which, although exceeding guidance, did not meet investor expectations […]",
      "url": "https://finnhub.io/api/news?id=1c4b12a3a1d1923c282b60335a2d45f08ef3ee21a579aecc925a47775107ab3a"
    }
  },
  {
    "ts": null,
    "headline": "Truist Financial Corp. stock outperforms competitors on strong trading day",
    "summary": "Truist Financial Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=7383386cb87e7562963be6fc8ef2efe3d9977cf274943acdc1a00b873421149f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750697220,
      "headline": "Truist Financial Corp. stock outperforms competitors on strong trading day",
      "id": 135505895,
      "image": "",
      "related": "TFC",
      "source": "MarketWatch",
      "summary": "Truist Financial Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=7383386cb87e7562963be6fc8ef2efe3d9977cf274943acdc1a00b873421149f"
    }
  },
  {
    "ts": null,
    "headline": "Truist Flags PayPal as a Weak Bet, Targets $68",
    "summary": "Truist Securities kicked off its coverage of PayPal (NASDAQ: PYPL) with a bearish stance in Early June, issuing a Sell rating and a $68 price target. The Firm’s analyst points to trouble ahead. PayPal is still a big name, but competition is eating into its core checkout business. Apple Pay and Shop Pay are crowding […]",
    "url": "https://finnhub.io/api/news?id=02fc067b105995ed855fcef3f4f73c296265cfa7661489f54608897a5c358706",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750692167,
      "headline": "Truist Flags PayPal as a Weak Bet, Targets $68",
      "id": 135482009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Truist Securities kicked off its coverage of PayPal (NASDAQ: PYPL) with a bearish stance in Early June, issuing a Sell rating and a $68 price target. The Firm’s analyst points to trouble ahead. PayPal is still a big name, but competition is eating into its core checkout business. Apple Pay and Shop Pay are crowding […]",
      "url": "https://finnhub.io/api/news?id=02fc067b105995ed855fcef3f4f73c296265cfa7661489f54608897a5c358706"
    }
  },
  {
    "ts": null,
    "headline": "Hims & Hers Health Faces Litigation Risk After Novo Nordisk 'Breakup,' Truist Says",
    "summary": "Novo Nordisk's (NVO) termination of its collaboration on the sale of weight loss drugs, including We",
    "url": "https://finnhub.io/api/news?id=0e7aa018b161877f0477770c02c1cf224283ff11fc10731d4b1b17f61591cd3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750690595,
      "headline": "Hims & Hers Health Faces Litigation Risk After Novo Nordisk 'Breakup,' Truist Says",
      "id": 135482113,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Novo Nordisk's (NVO) termination of its collaboration on the sale of weight loss drugs, including We",
      "url": "https://finnhub.io/api/news?id=0e7aa018b161877f0477770c02c1cf224283ff11fc10731d4b1b17f61591cd3b"
    }
  }
]